CN203074772U - Absorbable anti-adhesion diaphragm in uterine cavity of uterus - Google Patents
Absorbable anti-adhesion diaphragm in uterine cavity of uterus Download PDFInfo
- Publication number
- CN203074772U CN203074772U CN 201320068563 CN201320068563U CN203074772U CN 203074772 U CN203074772 U CN 203074772U CN 201320068563 CN201320068563 CN 201320068563 CN 201320068563 U CN201320068563 U CN 201320068563U CN 203074772 U CN203074772 U CN 203074772U
- Authority
- CN
- China
- Prior art keywords
- uterine cavity
- uterus
- adhesion
- diaphragm
- type skeleton
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Abstract
The utility model discloses an absorbable anti-adhesion diaphragm in the uterine cavity of uterus, and aims to solve the deficiency that the treatment effect is not ideal, intrauterine adhesion is easy to reappear, and adverse effects are easy to generate during treatment by an existing intrauterine adhesion treatment method. The absorbable anti-adhesion diaphragm in the uterine cavity of uterus comprises a sleeve and a push rod arranged in the sleeve, wherein a moveable positioning block is sleeved on the outer wall of the sleeve, and a biodegradable absorbable diaphragm body is arranged inside the front end of the sleeve. The diaphragm body comprises an elastic V-shaped framework which is connected and wrapped with a light and thin flexible diaphragm body. The V-shaped framework is arranged at the edge of the diaphragm body, and the opening of the V-shaped framework is arranged outward inside the front end of the sleeve. The absorbable anti-adhesion diaphragm in the uterine cavity of uterus can effectively prevent intrauterine adhesion, wherein the treatment effect is good, intrauterine adhesion is not easy to reappear, and untoward effects are difficult to generate during treatment. The absorbable anti-adhesion diaphragm in the uterine cavity of uterus is economic, safe, simple to operate and high in compliance of patients. The diaphragm is absorbable and does not need to be taken out after use, so that pain of patients is alleviated.
Description
Technical field
This utility model relates to a kind of medical field prevention uterus intrauterine adhesion device, and more particularly, it relates to a kind of uterus uterine cavity anti barrier film that can degrade voluntarily and need not to take out.
Background technology
Intrauterine adhesion (intrauterine adhesion.IUA) claim the Asherman syndrome again, show as the few or amenorrhea of menstrual blood volume, periodic abdominalgia, pregnancy early midtrimester abortion, repeatedly or habitual abortion, missed abortion, ectopic pregnancy, premature labor, fetal death in utero to reach the Placenta Hominis plantation unusual etc., have a strong impact on women's physical and mental health.Any destructive factor of endometrium that causes all can cause intrauterine adhesion, be common in the artificial abortion or the spontaneous abortion dilatation and curettage after.The intrauterine adhesion that non-gestation causes, as hysteromyoma evidement, diagnostic curettage art etc., comparatively rare.Have the scholar find the incidence rate of 1 operation back intrauterine adhesion be 6.3%, 2 time be 14%, and the person is 32% more than 3 times, prompting artificial abortion meeting increases the adhesion incidence rate, the many more probabilities of number of times are high more, and missed abortion and easier the sticking together of the residual person of Placenta Hominis.
In recent years along with the popularization and the application of artificial abortion's technology, artificial abortion's number, repeat artificial abortion's number of times cumulative year after year, the incidence rate of the postoperative intrauterine adhesion that causes thus also rises thereupon.The intrauterine adhesion exclusion is the main Therapeutic Method of present IUA under the hysteroscope, and it is that direct-view separates down or the interior adhesion of excision uterine cavity targetedly, mainly contains mechanicalness operation and the operation of energy apparatus.The former postoperative forms the few but anthemorrhagic difficulty in the art of cicatrix, and latter's haemostatic effect is good, operating time short but more easily form cicatrix.Have that intrauterine adhesion exclusion tissue adhesion relapse rate is 3.1～23.5% under the bibliographical information hysteroscope, the severe adhesion relapse rate is up to 20～62.5%.How to reduce the difficult problem that adherence recurrence also is a clinical treatment.The method of traditional prevention intrauterine adhesion is to keep somewhere birth control apparatus and the treatment of postoperative hormonal supplementation at electrotomy seraglio intracavity, but has the scholar to think that treatment of postoperative hormonal supplementation and the interior birth control apparatus prevention intrauterine adhesion of placing of uterine cavity do not have too big help abroad.Hardness because of rejection of cervix uteri condition uterus and birth control apparatus support behind a lot of clinically women's placing rack type metal contraceptive devices is big, factors such as shape is not inconsistent cause iud expulsion, hyper-menorrhea in shape and the uterine cavity, menostaxis, drop is hemorrhage, untoward reaction such as leucorrhoea grow in quantity and waist abdomen pain.The elasticity of the capable birth control apparatus of copper T is limited, yielding, and the situation of Zhang Bukai takes place sometimes.Usually need to take out T type birth control apparatus behind patient's postoperative menstrual onset 2 times.This will need to expand the palace once more to the patient, increase gynecologist's work load, also increase patient's body and mind misery.The intrauterine device that has tailfiber has in addition easily increased the probability that uterine cavity infects.The people of small part can be to copper allergy in addition.
What research was more at present is that uterine cavity is placed sacculus, hyaluronic acid sodium gel, hyaluronic acid sodium biological fibrin glue, medical chitose gel etc. behind the electrotomy.Have report to point out that type discharge Place capsule catheter can prevent intrauterine adhesion in the uterine cavity, but type discharge Place capsule catheter might suppress endometrial growth, even might cause the endometrium ischemic necrosis.Sacculus long more easy more infection standing time.Other products such as medical chitose gel etc. prevent that in fields such as surgery, department of obstetrics and gynecology, orthopaedics the postoperative tissue from having certain effect.But many clinically at present employing uterine cavities inject, because special shape, position and the action of gravity of uterine cavity, most gel all can be discharged with vagina, thereby has reduced the effect of medicine.
In sum, be used to prevent the various Therapeutic Method of intrauterine adhesion after the artificial abortion at present, therapeutic effect is undesirable, easily recurrence, and also treatment easily produces untoward reaction.Therefore, seek a kind of preventive measure safely and effectively, very important meaning is arranged.
Chinese patent notification number CN2166781Y, a kind of Uterus air pocket is disclosed, comprise two parts of air bag and attachment device, air bag is made up of pneumatophore and airbag neck, be used to support cavity of uterus after the pneumatophore inflation, the airbag neck side is adhered to aerating device and is made up of charge valve and gas tube in order to support cervix uteri, and charge valve is a valve inside.Uterus air pocket is used for the treatment of metrosynizesis, and Area of bearing is big, be difficult for deviating from, but effect is undesirable, and easily recurrence, and also treatment easily produces untoward reaction.
The utility model content
It is undesirable that this utility model has overcome the therapeutic effect of existing uterus Asherman's syndrom curing method, the easily recurrence of treatment back, and treatment easily produces the deficiency of untoward reaction, a kind of uterus uterine cavity anti barrier film that absorbs is provided, it can effectively prevent intrauterine adhesion, therapeutic effect is good, and the treatment back is difficult for recurrence, and treatment is difficult for producing untoward reaction.And economy, safety, simple to operate, patient's compliance height.Barrier film is absorbable, does not need after the use to take out, and has reduced patient's misery, and diaphragm main body is the magnetic tape trailer silk not, reduces the probability of retrograde infection.
In order to solve the problems of the technologies described above, this utility model is by the following technical solutions: a kind of uterus uterine cavity anti barrier film that absorbs, comprise sleeve pipe, be arranged on the push rod in the sleeve pipe, be socketed with the activity orientation piece on the sleeve outer wall, but sleeve pipe front end inside is provided with biodegradation absorbing septum main body, and diaphragm main body comprises elastic V-type skeleton, connects on the V-type skeleton to be coated with frivolous flexible foil body, the V-type skeleton is arranged on the edge of film body, and V-type skeleton opening is arranged on sleeve pipe front end inside outwardly.
Can absorb uterus uterine cavity anti barrier film in use, with folding back whole being stuck in the sleeve pipe of the V-type skeleton of diaphragm main body near end position.Hold sleeve pipe, adjust the position of activity orientation piece,, prevent from uterine cavity is produced injury so that control the degree of depth that diaphragm main body inserts uterine cavity flexibly according to the length of uterine cavity of measuring.Promote push rod then, push rod promotes diaphragm main body and sends into uterine cavity along cervical canal, and this moment is push rod fixedly, fixed sleeving behind the recession sleeve pipe 50mm, withdraw from push rod earlier, the reuse sleeve pipe drives diaphragm main body and pushes away forward gently, guarantees that diaphragm main body is put into uterine cavity and sleeve pipe is withdrawn from again.The diaphragm main body of putting into uterine cavity fully launches, be stuck in the two ends of angle, palace opening, be difficult in uterine cavity, coming off, increased the contact area of diaphragm main body and uterine cavity internal mold, with the uterine cavity front and rear wall separately, can effectively prevent intrauterine adhesion effectively, therapeutic effect is good, the treatment back is difficult for recurrence, and treatment is difficult for producing untoward reaction.And economy, safety, simple to operate, patient's compliance height.Because diaphragm main body is that biodegradation is absorbable, diaphragm main body is placed on can degrade after uterine cavity uses a period of time voluntarily, and does not need to take out, and has reduced the patient suffering.
As preferably, the V-type skeleton is made by a kind of material in the Biodegradable high-moleculars such as copolymer of poly-Acetic acid, hydroxy-, bimol. cyclic ester, polylactide or lactide and Acetic acid, hydroxy-, bimol. cyclic ester.Film body is made by a kind of material in the Biodegradable high-moleculars such as copolymer of poly-Acetic acid, hydroxy-, bimol. cyclic ester, polylactide or lactide and Acetic acid, hydroxy-, bimol. cyclic ester.By V-type skeleton and the film body that these biodegradable polymers are made, have under physiological condition degraded voluntarily, finally be degraded to monomer or carbon dioxide and water, thereby or absorbed by matrix or excrete by metabolic pathway.The copolymer (PLGA) of poly-Acetic acid, hydroxy-, bimol. cyclic ester (PGA), polylactide (PLA) or lactide and Acetic acid, hydroxy-, bimol. cyclic ester has good biocompatibility, and is safe in utilization.
As preferably, the outer end of push rod is fixedly connected with annular hand grip.Handle makes the promotion of push rod more convenient.
As preferably, V-type skeleton surface is provided with the spiral type location stricture of vagina of projection.Spiral type location stricture of vagina specifically has localized effect when ultrasonography.
Compared with prior art, the beneficial effects of the utility model are: (1) can absorb uterus uterine cavity anti barrier film can effectively prevent intrauterine adhesion, and therapeutic effect is good, and the treatment back is difficult for recurrence, and treatment is difficult for producing untoward reaction.And economy, safety, simple to operate, patient's compliance height; (2) because diaphragm main body is that biodegradation is absorbable, diaphragm main body is placed on can degrade after uterine cavity uses a period of time voluntarily, and does not need to take out, and has reduced the patient suffering, and diaphragm main body is the magnetic tape trailer silk not, reduces the probability of retrograde infection.
Description of drawings
Fig. 1 is a kind of structural representation of the present utility model;
Fig. 2 is the structural representation of diaphragm main body deployed condition of the present utility model;
Among the figure: 1, sleeve pipe, 2, push rod, 3, the activity orientation piece, 4, diaphragm main body, 5, the V-type skeleton, 6, film body, 7, handle.
The specific embodiment
Below by specific embodiment, and in conjunction with the accompanying drawings, the technical solution of the utility model is further described specifically:
Embodiment: a kind of uterus uterine cavity anti barrier film (referring to accompanying drawing 1) that absorbs, comprise straight sleeve pipe 1 that two ends are communicated with, be arranged on the push rod 2 in the sleeve pipe, the outer end of push rod is fixedly connected with annular handle 7, casing length 120mm, external diameter 5mm, internal diameter 4mm, push rod length 150mm.Be socketed with activity orientation piece 3 on the sleeve outer wall.Push rod can promote in sleeve pipe, and the activity orientation piece can slide on sleeve outer wall.But sleeve pipe front end inside is provided with the biodegradation absorbing septum main body 4(of V-type and participates in accompanying drawing 2), diaphragm main body is arranged in the sleeve pipe and can be promoted by push rod.Diaphragm main body comprises elastic V-type skeleton 5, connect on the V-type skeleton and be coated with frivolous flexible foil body 6, the V-type skeleton is arranged on the edge of film body, V-type skeleton opening is arranged on sleeve pipe front end inside outwardly, the A/F of V-type skeleton is 35mm, the length of V-type skeleton two arms is 28mm, and V-type skeleton diameter is 1.5mm.The two ends of V-type skeleton are the arc-shaped curved surface structure of evagination, and V-type skeleton surface is provided with the spiral type location stricture of vagina of projection, and the spiral positioning stricture of vagina specifically has localized effect when ultrasonography.The V-type skeleton is one-body molded, and the V-type skeleton is made by a kind of material in the copolymer of poly-Acetic acid, hydroxy-, bimol. cyclic ester, polylactide or lactide and Acetic acid, hydroxy-, bimol. cyclic ester, and the V-type skeleton is made by the copolymer of lactide and Acetic acid, hydroxy-, bimol. cyclic ester in the present embodiment.Film body is made by a kind of material in the copolymer of poly-Acetic acid, hydroxy-, bimol. cyclic ester, polylactide or lactide and Acetic acid, hydroxy-, bimol. cyclic ester, and the present embodiment mesosome is made by poly-Acetic acid, hydroxy-, bimol. cyclic ester.
Can absorb uterus uterine cavity anti barrier film in use, with the folding back whole close end position in the sleeve pipe that is stuck in of the rubber-like V-type skeleton of diaphragm main body, opening outwardly.Hold sleeve pipe, adjust the position of activity orientation piece,, prevent from uterine cavity is produced injury so that control the degree of depth that diaphragm main body inserts uterine cavity flexibly according to uterine cavity of measuring and cervical length.Promote push rod then, push rod promotes diaphragm main body and sends into uterine cavity at the bottom of the palace along cervical canal, at this moment fixing push rod, fixed sleeving behind the recession sleeve pipe 50mm, withdraw from push rod earlier, the reuse sleeve pipe drives diaphragm main body and pushes away forward gently, guarantees that diaphragm main body is put in the uterine cavity sleeve pipe to be withdrawn from again.The diaphragm main body of putting into uterine cavity fully launches, and V-type skeleton two ends are stuck in the two ends of angle, palace opening, is difficult for coming off in uterine cavity, has increased the contact area of diaphragm main body and uterine cavity internal mold, with the uterine cavity front and rear wall separately, can effectively prevent intrauterine adhesion effectively.Whole steps can be carried out under ultransonic guiding.
Above-described embodiment is a kind of preferable scheme of the present utility model, is not that this utility model is done any pro forma restriction, also has other variant and remodeling under the prerequisite that does not exceed the technical scheme that claim puts down in writing.
Claims (5)
1. one kind can absorb uterus uterine cavity anti barrier film, it is characterized in that, comprise sleeve pipe (1), be arranged on the push rod (2) in the sleeve pipe, be socketed with activity orientation piece (3) on the sleeve outer wall, but sleeve pipe front end inside is provided with biodegradation absorbing septum main body (4), and diaphragm main body comprises elastic V-type skeleton (5), connects on the V-type skeleton to be coated with frivolous flexible foil body (6), the V-type skeleton is arranged on the edge of film body, and V-type skeleton opening is arranged on sleeve pipe front end inside outwardly.
2. the uterus uterine cavity anti barrier film that absorbs according to claim 1 is characterized in that, the V-type skeleton is made by a kind of material in the copolymer of poly-Acetic acid, hydroxy-, bimol. cyclic ester, polylactide or lactide and Acetic acid, hydroxy-, bimol. cyclic ester.
3. the uterus uterine cavity anti barrier film that absorbs according to claim 1 is characterized in that, film body is made by a kind of material in the copolymer of poly-Acetic acid, hydroxy-, bimol. cyclic ester, polylactide or lactide and Acetic acid, hydroxy-, bimol. cyclic ester.
4. according to claim 1 or the 2 or 3 described uterus uterine cavity anti barrier films that absorb, it is characterized in that the outer end of push rod is fixedly connected with annular hand grip (7).
5. according to claim 1 or the 2 or 3 described uterus uterine cavity anti barrier films that absorb, it is characterized in that V-type skeleton surface is provided with the spiral type location stricture of vagina of projection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201320068563 CN203074772U (en) | 2013-02-01 | 2013-02-01 | Absorbable anti-adhesion diaphragm in uterine cavity of uterus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201320068563 CN203074772U (en) | 2013-02-01 | 2013-02-01 | Absorbable anti-adhesion diaphragm in uterine cavity of uterus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203074772U true CN203074772U (en) | 2013-07-24 |
Family
ID=48820661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201320068563 Expired - Lifetime CN203074772U (en) | 2013-02-01 | 2013-02-01 | Absorbable anti-adhesion diaphragm in uterine cavity of uterus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203074772U (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257419A (en) * | 2014-10-14 | 2015-01-07 | 中国人民解放军总医院 | Intrauterine adhesion blocker |
| CN106137346A (en) * | 2016-07-28 | 2016-11-23 | 山东中医药大学附属医院 | A kind of degradable uterine cavity Anti-adhering device |
| CN107951550A (en) * | 2017-12-14 | 2018-04-24 | 易浦润（上海）生物技术有限公司 | A kind of degradable inner membrane of uterine cavity implant system |
| CN109009646A (en) * | 2018-08-07 | 2018-12-18 | 浙江大学 | A kind of uterine cavity barrier device |
| CN112386376A (en) * | 2019-08-12 | 2021-02-23 | 石海波 | Uterus anti-adhesion support for preventing and treating uterus intrauterine adhesion and use method thereof |
-
2013
- 2013-02-01 CN CN 201320068563 patent/CN203074772U/en not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257419A (en) * | 2014-10-14 | 2015-01-07 | 中国人民解放军总医院 | Intrauterine adhesion blocker |
| CN106137346A (en) * | 2016-07-28 | 2016-11-23 | 山东中医药大学附属医院 | A kind of degradable uterine cavity Anti-adhering device |
| CN107951550A (en) * | 2017-12-14 | 2018-04-24 | 易浦润（上海）生物技术有限公司 | A kind of degradable inner membrane of uterine cavity implant system |
| CN109009646A (en) * | 2018-08-07 | 2018-12-18 | 浙江大学 | A kind of uterine cavity barrier device |
| CN112386376A (en) * | 2019-08-12 | 2021-02-23 | 石海波 | Uterus anti-adhesion support for preventing and treating uterus intrauterine adhesion and use method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11779372B2 (en) | Methods and devices for conduit occlusion | |
| CN203074772U (en) | Absorbable anti-adhesion diaphragm in uterine cavity of uterus | |
| US8048101B2 (en) | Methods and devices for conduit occlusion | |
| CN203074828U (en) | Anti-adhesion membrane for uterine cavity | |
| CN103417272A (en) | Medicine distribution type uterus support | |
| CN209203701U (en) | Contraceptive and its apparatus for placing in new bio degradable material uterine cavity-uterine neck | |
| CN203539420U (en) | Medicine-distribution type uterus stent | |
| CN205831888U (en) | Endometrium prosthetic device | |
| CN105902306B (en) | Endometrium prosthetic device | |
| CN205108700U (en) | Location is given and is covered medicine inflation bolt in vagina | |
| CN219594911U (en) | Intrauterine anti-adhesion device | |
| CN109330759A (en) | Contraceptive and its apparatus for placing in new bio degradable material uterine cavity-uterine neck | |
| CN211883982U (en) | Uterine cavity postoperative anti-adhesion device and pushing device thereof | |
| CN201542801U (en) | Intrauterine IUD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20130724 |